Author Archives: Steve Walker

GOP Senate health bill finally unveiled; Republicans now can say at least they tried to scrap Obamacare.






A lot of Americans, including all but literally a handful of our elected representatives, have been sitting on pins and needles, waiting for the Senate to divulge its version of… Read more »

Trump’s Exec Order on drug pricing proves he’s like the leopard; he can’t change his spots






A draft of President Donald Trump’s executive order on drug prices lists several proposals to lessen regulatory hurdles for the pharmaceutical industry, reports The New York Times. Here are four things… Read more »

Although more expensive, study says teaching hospitals save more lives. My personal take.






Perhaps not evident to many patients, there are two kinds of hospitals–teaching and nonteaching–and an intense debate about which is better. Teaching hospitals, affiliated with medical schools, are the training grounds… Read more »

Idorsia leaps 45% in market debut; Actelion spinoff looks like sure bet with J&J backing to boot. How to invest.






Idorsia Ltd. (Allschwil CHE), the research-based spin-out from Actelion following the latter’s $30 billion acquisition by Johnson & Johnson (New Brunswick NJ), which has now been completed, started trading on… Read more »

Merck’s Keytruda aces another cancer trial as results dazzle researchers






The News: Hot on the heels of the final presentation at ASCO’s 4-day conference in Chicago, a small, new study is causing jaws to drop after it found that a… Read more »

CDC weighs in with new Zika data, heightened warning about complacency






The News: Zika has gradually disappeared from the headlines, buried under the daily avalanche of news coming out of the nation’s capital and terror attacks in Europe. But on Thursday… Read more »

CAR-T Therapy: Personalized medicine with the promise of a cure; payers will decide who gets it






The News: Swiss drug giant Novartis AG has drawn widespread praise and a rising dose of controversy pertaining to its breakthrough CAR-T therapy CTL019. The medicine is under review to… Read more »

ASCO, aka The Oncology Super Bowl for Biotechs, sends stocks in every direction






Steve’s Take: As another jam-packed annual meeting of the American Society of Clinical Oncology in Chicago wrapped up on Tuesday (June 6, 2017), with some 38,000 oncologists gathering together at… Read more »

Tesaro says it’s for sale, but who can afford it






The News: Just ahead of the year’s biggest download of cancer data, the maker of a closely watched drug has put itself up for sale, according to The Wall Street… Read more »

Universal health care: a “right” or “privilege.” Wrong question, or already settled?






Steve’s Take: Bloomberg’s Ramesh Ponnuru poses the question: “Is there a ‘right’ to healthcare? Our arguments about health policy frequently highlight the question.” He goes on to say that “as… Read more »